We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NeuroMetrix Inc | NASDAQ:NURO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.08 | 1.79% | 4.55 | 4.25 | 5.50 | 4.45 | 4.28 | 4.45 | 21,219 | 05:00:07 |
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
04-3308180
|
(State or other jurisdiction of
|
(I.R.S. Employer Identification No.)
|
incorporation or organization)
|
|
|
|
1000 Winter Street, Waltham, Massachusetts
|
02451
|
(Address of principal executive offices)
|
(Zip Code)
|
Large accelerated filer
¨
|
Accelerated filer
¨
|
Non-accelerated filer
¨
|
Smaller reporting company
x
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
||
|
|
|
Item 1.
|
|
|
|
|
|
|
Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017
|
|
|
|
|
|
Statements of Operations (unaudited) for the Quarters and Six Months Ended June 30, 2018 and 2017
|
|
|
|
|
|
Statements of Cash Flows (unaudited) for the Six Months Ended June 30, 2018 and 2017
|
|
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
||
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
Item 5.
|
||
|
|
|
Item 6.
|
||
|
|
|
|
June 30, 2018
|
|
December 31, 2017
|
||||
|
(Unaudited)
|
|
|
||||
Assets
|
|
|
|
|
|
||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
7,108,915
|
|
|
$
|
4,043,681
|
|
Accounts receivable, net
|
1,114,496
|
|
|
1,049,329
|
|
||
Inventories
|
2,424,178
|
|
|
2,142,561
|
|
||
Prepaid expenses and other current assets
|
691,835
|
|
|
1,867,803
|
|
||
Total current assets
|
11,339,424
|
|
|
9,103,374
|
|
||
|
|
|
|
||||
Fixed assets, net
|
430,669
|
|
|
440,842
|
|
||
Other long-term assets
|
38,127
|
|
|
55,008
|
|
||
Total assets
|
$
|
11,808,220
|
|
|
$
|
9,599,224
|
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
|
|
|
|
||||
Accounts payable
|
$
|
799,785
|
|
|
$
|
733,305
|
|
Accrued expenses and compensation
|
1,974,210
|
|
|
2,362,124
|
|
||
Accrued product returns
|
1,312,618
|
|
|
666,375
|
|
||
Deferred revenue
|
—
|
|
|
820,031
|
|
||
Total current liabilities
|
4,086,613
|
|
|
4,581,835
|
|
||
|
|
|
|
||||
Total liabilities
|
4,086,613
|
|
|
4,581,835
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 6)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
|
||
Preferred stock
|
—
|
|
|
—
|
|
||
Convertible preferred stock
|
18
|
|
|
30
|
|
||
Common stock, $0.0001 par value; 100,000,000 shares authorized at June 30, 2018 and December 31, 2017; 7,356,731 and 2,706,066 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively
|
736
|
|
|
271
|
|
||
Additional paid-in capital
|
197,020,869
|
|
|
196,355,142
|
|
||
Accumulated deficit
|
(189,300,016
|
)
|
|
(191,338,054
|
)
|
||
Total stockholders’ equity
|
7,721,607
|
|
|
5,017,389
|
|
||
Total liabilities and stockholders’ equity
|
$
|
11,808,220
|
|
|
$
|
9,599,224
|
|
|
Six Months Ended June 30,
|
||||||
|
2018
|
|
2017
|
||||
Cash flows from operating activities:
|
|
|
|
|
|
||
Net income (loss)
|
$
|
1,740,180
|
|
|
$
|
(6,470,196
|
)
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||
Depreciation
|
140,989
|
|
|
126,254
|
|
||
Stock-based compensation
|
371,917
|
|
|
113,635
|
|
||
Change in fair value of warrant liability
|
—
|
|
|
(208,153
|
)
|
||
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
Accounts receivable
|
1,288,332
|
|
|
(245,786
|
)
|
||
Inventories
|
(281,617
|
)
|
|
(225,089
|
)
|
||
Prepaid expenses and other current and long-term assets
|
609,358
|
|
|
(53,464
|
)
|
||
Accounts payable
|
66,480
|
|
|
24,160
|
|
||
Accrued expenses and compensation
|
(93,651
|
)
|
|
367,295
|
|
||
Accrued product returns
|
(645,938
|
)
|
|
(71,388
|
)
|
||
Deferred revenue
|
—
|
|
|
31,037
|
|
||
Net cash provided by (used in) operating activities
|
3,196,050
|
|
|
(6,611,695
|
)
|
||
|
|
|
|
||||
Cash flows from investing activities:
|
|
|
|
|
|
||
Purchases of fixed assets
|
(130,816
|
)
|
|
(37,869
|
)
|
||
Net cash used in investing activities
|
(130,816
|
)
|
|
(37,869
|
)
|
||
|
|
|
|
||||
Cash flows from financing activities:
|
|
|
|
|
|
||
Net proceeds from issuance of stock and warrants
|
—
|
|
|
6,312,378
|
|
||
Net cash provided by financing activities
|
—
|
|
|
6,312,378
|
|
||
|
|
|
|
||||
Net increase (decrease) in cash and cash equivalents
|
3,065,234
|
|
|
(337,186
|
)
|
||
Cash and cash equivalents, beginning of period
|
4,043,681
|
|
|
3,949,135
|
|
||
Cash and cash equivalents, end of period
|
$
|
7,108,915
|
|
|
$
|
3,611,949
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||
Change in fair value of warrant liability from repricing
|
$
|
—
|
|
|
$
|
244,611
|
|
Common stock issued to settle employee incentive compensation obligation
|
$
|
294,264
|
|
|
$
|
—
|
|
1.
|
Business and Basis of Presentation
|
|
As reported
|
|
|
|
After adoption
|
||||||
|
Quarter Ended June 30, 2017
|
|
ASU 2014-09
Impact
|
|
Quarter Ended June 30, 2017
|
||||||
Revenues
|
$
|
4,310,059
|
|
|
$
|
503,484
|
|
|
$
|
4,813,543
|
|
Cost of revenues
|
$
|
2,639,402
|
|
|
$
|
371,714
|
|
|
$
|
3,011,116
|
|
Gross profit
|
$
|
1,670,657
|
|
|
$
|
131,770
|
|
|
$
|
1,802,427
|
|
Net loss applicable to common stockholders
|
$
|
(3,237,796
|
)
|
|
$
|
131,770
|
|
|
$
|
(3,106,026
|
)
|
Net loss per common share applicable to common stockholders, basic and diluted
|
$
|
(2.49
|
)
|
|
$
|
0.10
|
|
|
$
|
(2.39
|
)
|
|
As reported
|
|
|
|
After adoption
|
||||||
|
Six Months Ended June 30, 2017
|
|
ASU 2014-09
Impact
|
|
Six Months Ended June 30, 2017
|
||||||
Revenues
|
$
|
8,616,181
|
|
|
$
|
511,138
|
|
|
$
|
9,127,319
|
|
Cost of revenues
|
$
|
5,337,004
|
|
|
$
|
397,743
|
|
|
$
|
5,734,747
|
|
Gross profit
|
$
|
3,279,177
|
|
|
$
|
113,395
|
|
|
$
|
3,392,572
|
|
Net loss applicable to common stockholders
|
$
|
(10,511,878
|
)
|
|
$
|
113,395
|
|
|
$
|
(10,398,483
|
)
|
Net loss per common share applicable to common stockholders, basic and diluted
|
$
|
(9.12
|
)
|
|
$
|
0.10
|
|
|
$
|
(9.02
|
)
|
|
As reported
|
|
|
|
After adoption
|
||||||
|
December 31, 2017
|
|
ASU 2014-09
Impact |
|
December 31, 2017
|
||||||
|
|
|
|
|
|
||||||
Accounts receivable, net
|
$
|
1,049,329
|
|
|
$
|
1,353,499
|
|
|
$
|
2,402,828
|
|
Prepaid expenses and other current assets
|
$
|
1,867,803
|
|
|
$
|
(583,491
|
)
|
|
$
|
1,284,312
|
|
Total current assets
|
$
|
9,103,374
|
|
|
$
|
770,008
|
|
|
$
|
9,873,382
|
|
|
|
|
|
|
|
||||||
Accrued product returns
|
$
|
666,375
|
|
|
$
|
1,292,181
|
|
|
$
|
1,958,556
|
|
Deferred revenue
|
$
|
820,031
|
|
|
$
|
(820,031
|
)
|
|
$
|
—
|
|
Total current liabilities
|
$
|
4,581,835
|
|
|
$
|
472,150
|
|
|
$
|
5,053,985
|
|
|
|
|
|
|
|
||||||
Accumulated deficit
|
$
|
(191,338,054
|
)
|
|
$
|
297,858
|
|
|
$
|
(191,040,196
|
)
|
Total stockholders’ equity
|
$
|
5,017,389
|
|
|
$
|
297,858
|
|
|
$
|
5,315,247
|
|
2.
|
Comprehensive Income (Loss)
|
3.
|
Net Income (Loss) Per Common Share
|
|
Quarters Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net income (loss) applicable to common stockholders
|
$
|
573,928
|
|
|
$
|
(3,237,796
|
)
|
|
$
|
1,740,180
|
|
|
$
|
(10,511,878
|
)
|
|
|
|
|
|
|
|
|
||||||||
Weighted average number of common shares outstanding, basic
|
7,330,479
|
|
|
1,302,231
|
|
|
6,839,778
|
|
|
1,152,441
|
|
||||
Dilutive convertible preferred stock
|
6,584,674
|
|
|
—
|
|
|
6,980,585
|
|
|
—
|
|
||||
Weighted average number of common shares outstanding, dilutive
|
13,915,153
|
|
|
1,302,231
|
|
|
13,820,363
|
|
|
1,152,441
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income (loss) per common share applicable to common stockholders, basic
|
$
|
0.08
|
|
|
$
|
(2.49
|
)
|
|
$
|
0.25
|
|
|
$
|
(9.12
|
)
|
Net income (loss) per common share applicable to common stockholders, diluted
|
$
|
0.04
|
|
|
$
|
(2.49
|
)
|
|
$
|
0.13
|
|
|
$
|
(9.12
|
)
|
|
Quarters Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
Options
|
466,025
|
|
|
97,774
|
|
|
401,778
|
|
|
97,832
|
|
Warrants
|
459,375
|
|
|
4,845,186
|
|
|
459,375
|
|
|
4,619,920
|
|
Convertible preferred stock
|
—
|
|
|
3,883,251
|
|
|
—
|
|
|
3,042,295
|
|
Total
|
925,400
|
|
|
8,826,211
|
|
|
861,153
|
|
|
7,760,047
|
|
4.
|
Inventories
|
|
June 30, 2018
|
|
December 31, 2017
|
||||
Purchased components
|
$
|
1,481,398
|
|
|
$
|
505,293
|
|
Finished goods
|
942,780
|
|
|
1,637,268
|
|
||
|
$
|
2,424,178
|
|
|
$
|
2,142,561
|
|
5.
|
Accrued Expenses and Compensation
|
|
June 30, 2018
|
|
December 31, 2017
|
||||
Accrued compensation
|
$
|
534,467
|
|
|
$
|
786,184
|
|
Technology fees
|
450,000
|
|
|
450,000
|
|
||
Professional services
|
320,000
|
|
|
603,000
|
|
||
Advertising and promotion
|
189,700
|
|
|
127,361
|
|
||
Warranty reserve
|
151,321
|
|
|
160,800
|
|
||
Other
|
328,722
|
|
|
234,779
|
|
||
|
$
|
1,974,210
|
|
|
$
|
2,362,124
|
|
6.
|
Commitments and Contingencies
|
7.
|
Fair Value Measurements
|
|
|
|
Fair Value Measurements at June 30, 2018 Using
|
||||||||||||
|
June 30, 2018
|
|
Quoted Prices in
Active Markets for Identical Assets (Level 1) |
|
Significant Other
Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents
|
$
|
4,728,828
|
|
|
$
|
4,728,828
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Total
|
$
|
4,728,828
|
|
|
$
|
4,728,828
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
Fair Value Measurements at December 31, 2017 Using
|
||||||||||||
|
December 31, 2017
|
|
Quoted Prices in
Active Markets for Identical Assets (Level 1) |
|
Significant Other
Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents
|
$
|
1,744,965
|
|
|
$
|
1,744,965
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Total
|
$
|
1,744,965
|
|
|
$
|
1,744,965
|
|
|
$
|
—
|
|
|
$
|
—
|
|
8.
|
Credit Facility
|
9.
|
Stockholders’ Equity
|
|
June 30, 2018
|
|
December 31, 2017
|
||||
Preferred stock, $0.001 par value; 5,000,000 shares authorized at June 30, 2018 and December 31, 2017; no shares issued and outstanding at June 30, 2018 and December 31, 2017
|
$
|
—
|
|
|
$
|
—
|
|
Series B convertible preferred stock, $0.001 par value; 147,000 shares designated at June 30, 2018 and December 31, 2017; 500 shares issued and outstanding at June 30, 2018 and December 31, 2017
|
$
|
1
|
|
|
$
|
1
|
|
Series D convertible preferred stock, $0.001 par value; 21,300 shares designated at June 30, 2018 and December 31, 2017; 14,052.93 shares issued and outstanding at June 30, 2018 and December 31, 2017
|
$
|
14
|
|
|
$
|
14
|
|
Series E convertible preferred stock, $0.001 par value; 7,000 shares designated at June 30, 2018 and December 31, 2017; 3,260.70 and 7,000 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively
|
$
|
3
|
|
|
$
|
7
|
|
Series F convertible preferred stock, $0.001 par value; 10,621 shares designated at June 30, 2018 and December 31, 2017; zero and 7,927.05 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively
|
$
|
—
|
|
|
$
|
8
|
|
|
Quarters Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
Revenues
|
$
|
3,751.6
|
|
|
$
|
4,310.1
|
|
|
$
|
(558.5
|
)
|
|
(13.0
|
)%
|
|
Quarters Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
Cost of revenues
|
$
|
1,950.3
|
|
|
$
|
2,639.4
|
|
|
$
|
(689.1
|
)
|
|
(26.1
|
)%
|
|
|
|
|
|
|
|
|
|||||||
Gross profit
|
$
|
1,801.3
|
|
|
$
|
1,670.7
|
|
|
$
|
130.6
|
|
|
7.8
|
%
|
|
Quarters Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Research and development
|
$
|
1,616.9
|
|
|
$
|
877.6
|
|
|
$
|
739.3
|
|
|
84.2
|
%
|
Sales and marketing
|
2,200.9
|
|
|
2,919.3
|
|
|
(718.4
|
)
|
|
(24.6
|
)%
|
|||
General and administrative
|
1,170.6
|
|
|
1,245.3
|
|
|
(74.7
|
)
|
|
(6.0
|
)%
|
|||
Total operating expenses
|
$
|
4,988.4
|
|
|
$
|
5,042.2
|
|
|
$
|
(53.8
|
)
|
|
(1.1
|
)%
|
|
Quarters Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||
Collaboration income
|
$
|
3,750.0
|
|
|
$
|
—
|
|
|
$
|
3,750.0
|
|
|
100.0
|
%
|
|
Quarters Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||
Other income
|
$
|
11.0
|
|
|
$
|
133.8
|
|
|
$
|
(122.8
|
)
|
|
(91.8
|
)%
|
|
Six Months Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
Revenues
|
$
|
8,694.6
|
|
|
$
|
8,616.2
|
|
|
$
|
78.4
|
|
|
0.9
|
%
|
|
Six Months Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
Cost of revenues
|
$
|
4,905.6
|
|
|
$
|
5,337.0
|
|
|
$
|
(431.4
|
)
|
|
(8.1
|
)%
|
|
|
|
|
|
|
|
|
|||||||
Gross profit
|
$
|
3,789.0
|
|
|
$
|
3,279.2
|
|
|
$
|
509.8
|
|
|
15.5
|
%
|
|
Six Months Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|||
Research and development
|
$
|
2,896.4
|
|
|
$
|
1,780.9
|
|
|
$
|
1,115.5
|
|
|
62.6
|
%
|
Sales and marketing
|
4,705.6
|
|
|
5,517.0
|
|
|
(811.4
|
)
|
|
(14.7
|
)%
|
|||
General and administrative
|
2,974.8
|
|
|
2,667.1
|
|
|
307.7
|
|
|
11.5
|
%
|
|||
Total operating expenses
|
$
|
10,576.8
|
|
|
$
|
9,965.0
|
|
|
$
|
611.8
|
|
|
6.1
|
%
|
|
Six Months Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||
Collaboration income
|
$
|
8,505.7
|
|
|
$
|
—
|
|
|
$
|
8,505.7
|
|
|
100.0
|
%
|
|
Six Months Ended June 30,
|
|
|
|||||||||||
|
2018
|
|
2017
|
|
Change
|
|
% Change
|
|||||||
|
(in thousands)
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||
Other income
|
$
|
22.3
|
|
|
$
|
215.6
|
|
|
$
|
(193.3
|
)
|
|
(89.7
|
)%
|
|
June 30, 2018
|
|
December 31, 2017
|
|
Change
|
|
% Change
|
|||||||
|
($ in thousands)
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||
Cash and cash equivalents
|
$
|
7,108.9
|
|
|
$
|
4,043.7
|
|
|
$
|
3,065.2
|
|
|
75.8
|
%
|
|
Quarters Ended June 30,
|
|
Year Ended
December 31, |
||
|
2018
|
|
2017
|
|
2017
|
|
|
|
|
|
|
Days sales outstanding (days)
|
32
|
|
32
|
|
37
|
Inventory turnover rate (times per year)
|
3.6
|
|
7.8
|
|
6.5
|
|
Six Months Ended June 30,
|
||||||
|
2018
|
|
2017
|
||||
|
(in thousands)
|
||||||
Net cash used in operating activities (excluding collaboration income)
|
$
|
(5,309.6
|
)
|
|
$
|
(6,611.7
|
)
|
Net cash provided by collaboration income
|
8,505.7
|
|
|
—
|
|
||
Net cash provided by (used in) operating activities
|
$
|
3,196.1
|
|
|
$
|
(6,611.7
|
)
|
Net cash used in investing activities
|
$
|
(130.8
|
)
|
|
$
|
(37.9
|
)
|
Net cash provided by financing activities
|
$
|
—
|
|
|
$
|
6,312.4
|
|
|
|
NEUROMETRIX, INC.
|
|
|
|
July 19, 2018
|
/s/
|
SHAI N. GOZANI, M.D., PH. D.
|
|
|
Shai N. Gozani, M.D., Ph. D.
|
|
|
Chairman, President and Chief Executive Officer
|
|
|
|
July 19, 2018
|
/s/
|
THOMAS T. HIGGINS
|
|
|
Thomas T. Higgins
|
|
|
Senior Vice President, Chief Financial Officer and Treasurer
|
Exhibit No.
|
|
Description
|
|
|
|
|
Lease Extension #1 dated June 14, 2018, between Cummings Properties, LLC and NeuroMetrix, Inc.
|
|
|
|
|
|
Certification of Principal Executive Officer Under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002. Filed herewith.
|
|
|
|
|
|
Certification of Principal Financial Officer Required Under Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Filed herewith.
|
|
|
|
|
|
Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350. Furnished herewith.
|
|
|
|
|
101
|
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) Balance Sheets at June 30, 2018 and December 31, 2017, (ii) Statements of Operations for the quarters and six months ended June 30, 2018 and 2017, (iii) Statements of Cash Flows for the six months ended June 30, 2018 and 2017, and (iv) Notes to Financial Statements.
|
|
|
1 Year NeuroMetrix Chart |
1 Month NeuroMetrix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions